<DOC>
	<DOCNO>NCT00963183</DOCNO>
	<brief_summary>The aim study ass safety , tolerability , pharmacokinetics pharmacodynamics AZD5423 follow single ascend dose administration healthy male subject .</brief_summary>
	<brief_title>AZD5423 Single Ascending Dose Study</brief_title>
	<detailed_description />
	<criteria>Provision sign , write date informed consent prior study specific procedure Have body mass index ( BMI ) 18 30 kg/m2 weigh least 50 kg 100 kg Any clinically significant disease disorder Any clinically significant abnormality screen examination Use prescribe nonprescribed medication</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>Safety</keyword>
	<keyword>Tolerability</keyword>
	<keyword>Healthy</keyword>
	<keyword>Inhalation</keyword>
</DOC>